BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 27444787)

  • 1. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.
    Mikuła-Pietrasik J; Uruski P; Matuszkiewicz K; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
    Cell Oncol (Dordr); 2016 Oct; 39(5):473-481. PubMed ID: 27444787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in vitro and in a mouse xenograft model in vivo.
    Mikuła-Pietrasik J; Sosińska P; Naumowicz E; Maksin K; Piotrowska H; Woźniak A; Szpurek D; Książek K
    Clin Exp Metastasis; 2016 Jan; 33(1):15-27. PubMed ID: 26433963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-Carnosine Prevents the Pro-cancerogenic Activity of Senescent Peritoneal Mesothelium Towards Ovarian Cancer Cells.
    Mikuła-Pietrasik J; Książek K
    Anticancer Res; 2016 Feb; 36(2):665-71. PubMed ID: 26851022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress contributes to hepatocyte growth factor-dependent pro-senescence activity of ovarian cancer cells.
    Mikuła-Pietrasik J; Uruski P; Pakuła M; Maksin K; Szubert S; Woźniak A; Naumowicz E; Szpurek D; Tykarski A; Książek K
    Free Radic Biol Med; 2017 Sep; 110():270-279. PubMed ID: 28652056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer-promoting activity of the senescent peritoneal mesothelium.
    Mikuła-Pietrasik J; Sosińska P; Maksin K; Kucińska MG; Piotrowska H; Murias M; Woźniak A; Szpurek D; Książek K
    Oncotarget; 2015 Oct; 6(30):29178-95. PubMed ID: 26284488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases.
    Mikuła-Pietrasik J; Uruski P; Sosińska P; Maksin K; Piotrowska-Kempisty H; Kucińska M; Murias M; Szubert S; Woźniak A; Szpurek D; Sajdak S; Piwocka K; Tykarski A; Książek K
    Cell Death Dis; 2016 Dec; 7(12):e2565. PubMed ID: 28032864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal mesothelium promotes the progression of ovarian cancer cells in vitro and in a mice xenograft model in vivo.
    Mikuła-Pietrasik J; Sosińska P; Kucińska M; Murias M; Maksin K; Malińska A; Ziółkowska A; Piotrowska H; Woźniak A; Książek K
    Cancer Lett; 2014 Dec; 355(2):310-5. PubMed ID: 25301450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells.
    Nakamura K; Sawada K; Kinose Y; Yoshimura A; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Morishige KI; Kurachi H; Lengyel E; Kimura T
    Mol Cancer Res; 2017 Jan; 15(1):78-92. PubMed ID: 27758876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.
    Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A
    Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway.
    Matte I; Garde-Granger P; Bessette P; Piché A
    BMC Cancer; 2019 Apr; 19(1):406. PubMed ID: 31039761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of malignant ascites on human mesothelial cells and their gene expression profiles.
    Matte I; Lane D; Bachvarov D; Rancourt C; Piché A
    BMC Cancer; 2014 Apr; 14():288. PubMed ID: 24761768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant Ascites Promote Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium and Fibroblasts.
    Uruski P; Mikuła-Pietrasik J; Pakuła M; Budkiewicz S; Drzewiecki M; Gaiday AN; Wierzowiecka M; Naumowicz E; Moszyński R; Tykarski A; Książek K
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bystander senescence in human peritoneal mesothelium and fibroblasts is related to thrombospondin-1-dependent activation of transforming growth factor-β1.
    Mikuła-Pietrasik J; Sosińska P; Janus J; Rubiś B; Brewińska-Olchowik M; Piwocka K; Książek K
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2087-96. PubMed ID: 23871936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical composition of malignant ascites determines high aggressiveness of undifferentiated ovarian tumors.
    Mikuła-Pietrasik J; Uruski P; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
    Med Oncol; 2016 Aug; 33(8):94. PubMed ID: 27431203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria-related oxidative stress contributes to ovarian cancer-promoting activity of mesothelial cells subjected to malignant ascites.
    Pakuła M; Mikuła-Pietrasik J; Stryczyński Ł; Uruski P; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
    Int J Biochem Cell Biol; 2018 May; 98():82-88. PubMed ID: 29550585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and growth patterns of human peritoneal mesothelial cells: comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources.
    Zhang XY; Pettengell R; Nasiri N; Kalia V; Dalgleish AG; Barton DP
    J Soc Gynecol Investig; 1999; 6(6):333-40. PubMed ID: 10643588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-β derived from ovarian cancer.
    Fujikake K; Kajiyama H; Yoshihara M; Nishino K; Yoshikawa N; Utsumi F; Suzuki S; Niimi K; Sakata J; Mitsui H; Shibata K; Senga T; Kikkawa F
    Oncol Rep; 2018 Jan; 39(1):193-200. PubMed ID: 29192324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
    Stadlmann S; Amberger A; Pollheimer J; Gastl G; Offner FA; Margreiter R; Zeimet AG
    Gynecol Oncol; 2005 Jun; 97(3):784-9. PubMed ID: 15943987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-to-Mesenchymal Transition and Migration of Human Peritoneal Mesothelial Cells Undergoing Senescence.
    Kawka E; Witowski J; Sandoval P; Rudolf A; Vidal AR; Cabrera ML; Jörres A
    Perit Dial Int; 2019; 39(1):35-41. PubMed ID: 30478141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.
    Yasui H; Kajiyama H; Tamauchi S; Suzuki S; Peng Y; Yoshikawa N; Sugiyama M; Nakamura K; Kikkawa F
    Clin Exp Metastasis; 2020 Feb; 37(1):145-158. PubMed ID: 31541326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.